Christine Coyne
Chief Commercial Officer · Iterum Therapeutics plc
Individual
- 2025
- Jul 1, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christine Coyne files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael W. Dunne - $2K in ITRM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christine Coyne?
Christine Coyne is a corporate insider, tracked as Chief Commercial Officer of Iterum Therapeutics plc (ITRM). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Christine Coyne last file a Form 4?
The only primary Form 4 on record is dated 1 July 2025.